Journal article

Adalimumab Efficacy in Hidradenitis Suppurativa Patients is Sustained at Least Three Years with Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER)

Christos C Zouboulis, Martin M Okun, Robert Gniadecki, Peter A Foley, Charles Lynde, Jamie Weisman, Piyalal Karunaratne, David A Williams

SKIN The Journal of Cutaneous Medicine | National Society for Cutaneous Medicine

DOI: 10.25251/skin.1.supp.127

Abstract

Abstract Not AvailableDisclosures: Study supported by AbbVie.

Citation metrics

2Dimensions